凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688065 凯赛生物

已收盘 12-20 15:00:00

{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":42.02,"timestamp":1734678000000,"preClose":42.5,"halted":0,"volume":2539278,"delay":0,"floatShares":583000000,"shares":583000000,"eps":0.682,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.48,"latestTime":"12-20 15:00:00","open":42.45,"high":42.49,"low":42.02,"amount":107000000,"amplitude":0.0111,"askPrice":42.04,"askSize":6,"bidPrice":42.02,"bidSize":100,"shortable":0,"etf":0,"ttmEps":0.682,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":42.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":46.75,"lowLimit":38.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":583378039,"pbRate":2.15,"roa":"--","roe":"3.04%","epsLYR":0.63,"committee":0.691932,"marketValue":24514000000,"floatMarketCap":24514000000,"peRate":61.612905,"changeRate":-0.0113,"turnoverRate":0.0044,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-23。","afterMarket":{"amount":0,"volume":0,"close":42.02,"buyVolume":0,"sellVolume":0,"time":1734680038975,"indexStatus":"已收盘 12-20 15:30:00","preClose":42.5}},"requestUrl":"/m/hq/s/688065","defaultTab":"news","newsList":[{"id":"2492090638","title":"凯赛生物，百亿级项目进展！","url":"https://stock-news.laohu8.com/highlight/detail?id=2492090638","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492090638?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:00","pubTimestamp":1734516000,"startTime":"0","endTime":"0","summary":"国内领先的生物基材料企业凯赛生物在市场发展上取得了显著进展。据了解，凯赛生物与招商局集团的百亿级生物基聚酰胺合作项目即将进入新阶段。凯赛生物与招商局集团合作新动态凯赛生物近期发布了多项公告，披露了与招商局集团合作的三大进展，同时公司的最大股东也将发生变化。0166亿定增计划获批2023年6月，凯赛生物披露了一项定增预案，计划定向增发不超过66亿元，引入招商局集团作为间接股东，并签署业务合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-18/doc-inczwpwu1026183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2492880948","title":"凯赛生物（688065）12月17日主力资金净买入620.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492880948","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492880948?lang=zh_cn&edition=full","pubTime":"2024-12-18 08:21","pubTimestamp":1734481274,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月17日收盘，凯赛生物报收于43.06元，上涨0.14%，换手率0.41%，成交量2.39万手，成交额1.03亿元。近5日资金流向一览见下表：凯赛生物融资融券信息显示，融资方面，当日融资买入744.68万元，融资偿还778.0万元，融资净偿还33.31万元。凯赛生物主营业务：利用生物制造技术,从事新型生物基材料的研发、生产及销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800008512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2492236963","title":"凯赛生物收购人增持股份至36.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492236963","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492236963?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:11","pubTimestamp":1734437515,"startTime":"0","endTime":"0","summary":"收购人将获得CIB持有的1.17亿股公司股份，同时以现金方式认购不超过1.54亿股新发行股份。若按上限计算，前述事项完成后，收购人将持有公司36.67%的股份，CIB持股比例将降至6.59%。本次收购后，收购人及其一致行动人持股比例合计将达到45.24%。收购人承诺在股份发行结束后60个月内不转让所认购的股份。2024年前三季度，凯赛生物实现收入22.15亿元，归母净利润3.45亿元。文章来源：财中社凯赛生物收购人增持股份至36.67%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217201940a1f5c534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217201940a1f5c534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2491161514","title":"凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491161514","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491161514?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:37","pubTimestamp":1734352655,"startTime":"0","endTime":"0","summary":"此次投资构成关联交易，但不构成重大资产重组。投资完成后，公司预计不会对2024年度的经营业绩产生重大影响，且不损害上市公司及股东的利益。2024年前三季度，凯赛生物实现收入22.15亿元，归母净利润3.45亿元。文章来源：财中社凯赛生物拟与创科生物、上海曜建共同投资设立合伙企业 合计出资额5010万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216211013a1f31dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2491166427","title":"凯赛生物(688065.SH)拟参投曜酰生物技术(上海)合伙企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166427","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491166427?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:51","pubTimestamp":1734349876,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物(688065.SH)发布公告，公司拟与招商创科生物技术(深圳)有限公司(简称“创科生物”)、上海曜建生物科技有限责任公司(简称“上海曜建”)共同投资设立曜酰生物技术(上海)合伙企业(有限合伙)(以企业登记机关最终的核准登记为准)(简称“上海曜酰”)。其中，公司作为有限合伙人出资2550万元，占比50.90%，创科生物作为有限合伙人出资2450万元，占比48.90%，上海曜建作为普通合伙人出资10万元，占比0.20%。所有投资人均以货币形式认缴，并按照各自出资比例履行出资义务。上海曜酰设立完成后，拟用于投资设立从事生物基聚酰胺复合材料业务的相关主体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2491615140","title":"凯赛生物：公司控股股东将由CIB变更为上海曜修","url":"https://stock-news.laohu8.com/highlight/detail?id=2491615140","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491615140?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:37","pubTimestamp":1734349028,"startTime":"0","endTime":"0","summary":"为实现CIB拟出资股票的过户，CIB与上海曜修于2024年12月16日签署本《股票出资协议之补充协议暨股份转让协议》。本次《股份转让协议》所涉及公司权益变动完成后，公司控股股东将由CIB变更为上海曜修，公司实际控制人仍为XIUCAILIU(刘修才)家庭。请读者仅作参考，并请自行承担全部责任。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216194200ab7c3efc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216194200ab7c3efc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2491166453","title":"凯赛生物最新公告：控股股东拟变更为上海曜修","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166453","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491166453?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:30","pubTimestamp":1734348610,"startTime":"0","endTime":"0","summary":"凯赛生物公告，根据公司控股股东CIB于2023年6月25日签署的《股票出资协议》等相关约定，作为公司2023年度向特定对象发行A股股票事项整体方案的一部分，CIB拟将其直接持有的公司116,655,640股人民币普通股A股股份对上海曜修生物技术合伙企业进行出资以认缴其合伙份额。本次《股份转让协议》所涉及公司权益变动完成后，公司控股股东将由CIB变更为上海曜修，公司实际控制人仍为XIUCAI LIU（刘修才）家庭。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600027059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2491615143","title":"凯赛生物12月16日主力资金流出1456万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491615143","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491615143?lang=zh_cn&edition=full","pubTime":"2024-12-16 15:19","pubTimestamp":1734333559,"startTime":"0","endTime":"0","summary":"12月16日, 凯赛生物股价跌2.54%，报收43.00元，成交金额1.27亿元，换手率0.50%，振幅3.99%，量比0.86。凯赛生物今日主力资金净流出1456万元，连续5日净流出，上一交易日主力净流出819万元，今日环比增加77.78%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为85.71%，平均跌幅为3.14%。该股近5个交易日下跌4.04%，主力资金累计净流出5195万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1595万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216153127a1f25d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216153127a1f25d6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2491334611","title":"凯赛生物12月12日遭主力抛售1429万元 环比增加182.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491334611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491334611?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:19","pubTimestamp":1733987961,"startTime":"0","endTime":"0","summary":"12月12日, 凯赛生物股价跌0.79%，报收45.01元，成交金额1.31亿元，换手率0.50%，振幅1.87%，量比0.92。凯赛生物今日主力资金净流出1429万元，连续3日净流出，上一交易日主力净流出506万元，今日环比增加182.41%。该股近5个交易日上涨0.92%，主力资金累计净流出2038万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3950万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212153208ab71c207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212153208ab71c207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2490867372","title":"基础化工行业周报：合成生物学周报：凯赛生物66亿定增落地，深圳合成生物等75亿元产业基金落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2490867372","media":"华安证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490867372?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:05","pubTimestamp":1733933140,"startTime":"0","endTime":"0","summary":"凯赛生物定增正式落地，招商局66亿元入局2024年12月4日，凯赛生物66亿元定向增发预案获得中国证监会同意注册批复，标志着这一不超过66亿元的定增方案正式落地。此次定增的核心目的在于引入招商局集团成为间接股东，并与招商局签署业务合作协议，聚焦生物基聚酰胺材料方面的深度合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000541a1e69a9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212000541a1e69a9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2489286470","title":"凯赛生物12月06日遭主力抛售1053万元 环比增加185.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286470","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286470?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:20","pubTimestamp":1733469615,"startTime":"0","endTime":"0","summary":"12月06日, 凯赛生物股价涨0.67%，报收44.90元，成交金额1.33亿元，换手率0.51%，振幅3.34%，量比1.08。凯赛生物今日主力资金净流出1053万元，上一交易日主力净流出369万元，今日环比增加185.37%。|12月06日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|欣灵电气|13.15%|#|如意集团|6.65%|#|东方智造|6.35%|#|佳云科技|6.35%|#|盛天网络|6.02%|#|鸿博股份|5.80%|#|泰尔股份|5.74%|#|酷特智能|5.29%|#|返利科技|4.59%|#|喜悦智行|3.89%|凯赛生物所在的化学制品行业，今日主力净流出9482万元，行业排名18/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153522a1d888fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206153522a1d888fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2488153402","title":"凯赛生物12月04日获主力加仓2574万元 环比增加1119.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488153402","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488153402?lang=zh_cn&edition=full","pubTime":"2024-12-04 15:20","pubTimestamp":1733296814,"startTime":"0","endTime":"0","summary":"12月04日, 凯赛生物股价涨0.58%，报收45.27元，成交金额1.54亿元，换手率0.58%，振幅3.55%，量比1.36。凯赛生物今日主力资金净流入2574万元，连续7日净流入，上一交易日主力净流入211万元，今日环比增加1119.91%。该股近5个交易日上涨0.27%，主力资金累计净流入3770万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入7614万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153813abf4e86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204153813abf4e86a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2488992406","title":"凯赛生物(688065.SH)：定增申请获中国证监会同意","url":"https://stock-news.laohu8.com/highlight/detail?id=2488992406","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488992406?lang=zh_cn&edition=full","pubTime":"2024-12-03 18:32","pubTimestamp":1733221927,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物(688065.SH)发布公告，公司于近日收到中国证券监督管理委员会出具的《关于同意上海凯赛生物技术股份有限公司向特定对象发行股票注册的批复》(证监许可〔2024〕1662号)。中国证监会同意公司向特定对象发行股票的注册申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2488994756","title":"凯赛生物最新公告：向特定对象发行A股股票申请获中国证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2488994756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488994756?lang=zh_cn&edition=full","pubTime":"2024-12-03 18:21","pubTimestamp":1733221264,"startTime":"0","endTime":"0","summary":"凯赛生物公告，公司于近日收到中国证券监督管理委员会出具的《关于同意上海凯赛生物技术股份有限公司向特定对象发行股票注册的批复》。根据批复文件，证监会同意公司向特定对象发行股票的注册申请。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120300032690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","BK0208","688065","399300"],"gpt_icon":0},{"id":"2488462826","title":"凯赛生物12月02日获主力加仓780万元 环比增加1292.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488462826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488462826?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:20","pubTimestamp":1733124004,"startTime":"0","endTime":"0","summary":"12月02日, 凯赛生物股价涨1.41%，报收45.30元，成交金额1.34亿元，换手率0.51%，振幅4.23%，量比1.22。凯赛生物今日主力资金净流入780万元，连续5日净流入，上一交易日主力净流入56万元，今日环比增加1292.86%。该股近5个交易日下跌0.11%，主力资金累计净流入1796万元；近20日主力资金累计净流入5786万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202153500abef07d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202153500abef07d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2486848207","title":"凯赛生物：首次回购约3.36万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486848207","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486848207?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:56","pubTimestamp":1732697792,"startTime":"0","endTime":"0","summary":"每经AI快讯，凯赛生物 11月27日晚间发布公告称，2024年11月27日，公司通过上海证券交易所交易系统以集中竞价交易方式首次回购公司股份约3.36万股占公司总股本约5.83亿股的比例为0.0058%，回购成交的最高价为45.3元/股，最低价为44.08元/股，支付的资金总额为人民币约150万元。2023年1至12月份，凯赛生物的营业收入构成为：合成生物材料行业占比97.77%。截至发稿，凯赛生物市值为263亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127165721abe2c845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127165721abe2c845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2486194748","title":"凯赛生物11月27日获主力加仓683万元 环比增加429.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486194748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486194748?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:20","pubTimestamp":1732692015,"startTime":"0","endTime":"0","summary":"11月27日, 凯赛生物股价涨1.46%，报收45.15元，成交金额1.03亿元，换手率0.40%，振幅4.11%，量比0.92。凯赛生物今日主力资金净流入683万元，上一交易日主力净流入129万元，今日环比增加429.46%。|11月27日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|中仑新材|8.78%|#|恒信东方|7.99%|#|岭南股份|7.89%|#|康冠科技|6.15%|#|华如科技|6.12%|#|天地在线|5.89%|#|汇金科技|5.75%|#|汤姆猫|5.14%|#|方直科技|5.05%|#|跨境通|4.94%|凯赛生物所在的化学制品行业，今日主力净流出4571万元，行业排名26/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153108a2591ea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127153108a2591ea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2486771603","title":"凯赛生物11月25日主力资金流出603万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486771603","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486771603?lang=zh_cn&edition=full","pubTime":"2024-11-25 15:19","pubTimestamp":1732519176,"startTime":"0","endTime":"0","summary":"11月25日, 凯赛生物股价涨3.00%，报收45.35元，成交金额1.48亿元，换手率0.57%，振幅4.57%，量比1.24。凯赛生物今日主力资金净流出603万元，连续3日净流出，上一交易日主力净流出1526万元，今日环比减少60.48%。该股近5个交易日下跌1.46%，主力资金累计净流出1497万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出414万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125153244abdd234d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125153244abdd234d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2485238899","title":"凯赛生物11月22日遭主力抛售1526万元 环比增加767.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485238899","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485238899?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:20","pubTimestamp":1732260029,"startTime":"0","endTime":"0","summary":"11月22日, 凯赛生物股价跌5.05%，报收44.03元，成交金额1.19亿元，换手率0.45%，振幅5.13%，量比0.87。凯赛生物今日主力资金净流出1526万元，上一交易日主力净流出176万元，今日环比增加767.05%。该股近5个交易日下跌5.94%，主力资金累计净流出2963万元；近20日主力资金累计净流入3023万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153913abd6be71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153913abd6be71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2485284202","title":"凯赛生物跌5% 券商多看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2485284202","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485284202?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:00","pubTimestamp":1732258803,"startTime":"0","endTime":"0","summary":"11月22日，凯赛生物股价大幅下跌，截至15点00分，凯赛生物下跌5.05%，报44.03元/股，创近1个月新低，成交1.19亿元，换手率0.45%。资金动向截止发稿，凯赛生物获得主力净流出1526万元，其中超大单流出1496万元，大单流出29万元。最新财报显示，今年三季报，凯赛生物实现营业收入22.15亿元，同比增长41.49%，净利润为3.45亿元，同比增长9.97%，基本每股收益为0.59元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150806abd6a97e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150806abd6a97e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","stockEarnings":[{"period":"1week","weight":-0.0476},{"period":"1month","weight":-0.1031},{"period":"3month","weight":0.2733},{"period":"6month","weight":-0.1036},{"period":"1year","weight":-0.2034},{"period":"ytd","weight":-0.232}],"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","perCapita":"60965股","boardName":"化学纤维制造业","registeredCapital":"58337万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":"　　上海凯赛生物技术股份有限公司从事新型生物基材料的研发、生产及销售。公司目前主要产品为生物法长链二元酸系列产品、生物基聚酰胺及单体产品等。公司重视打造技术竞争力，坚持走自主创新的发展道路，截至报告期末公司拥有318项发明专利在内的406项专利，获得国际纺织制造商联合会（ITMF）颁发的“《可持续与创新奖》（SUSTAINABILITY&INNOVATION）”，被认定为“国家企业技术中心”、“国家级第三批专精特新‘小巨人’企业”、“国家知识产权局优势企业”。","serverTime":1734747345902,"listedPrice":133.45,"stockholders":"9569人(较上一季度减少1.86%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}